“solid-biosciences” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
FDA Lifts Solid Bio Clinical Hold, Duchenne Study Cleared to Resume 10/01/20 Boston
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track 01/09/20 Boston
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial 11/12/19 Boston
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
With Its First Human Data, Solid Slips in Duchenne Gene Therapy Race 02/07/19 Boston
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Sarepta Touts New Data and a “Signal” With Duchenne Gene Therapy 10/03/18 Boston
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
Sarepta’s Data Are First in Rush for Duchenne Gene Therapy 06/19/18 Boston
As Sarepta Preps Data, FDA Lifts Hold on Solid’s Duchenne Gene Therapy 06/18/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Bio Roundup: DIY Biohacking, PCSK9 Data, Solid Setback & More 03/16/18 National
Solid Discloses More Problems As FDA Halts Duchenne Gene Therapy Study 03/14/18 Boston
After Paper Shakes Sector, Gene Therapy Leader Jim Wilson Talks Safety 01/30/18 National
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Solid Discloses Duchenne Problems in IPO & Raises Rival’s Hackles 01/25/18 Boston
With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up 11/08/17 Boston
Last Chance to Save on Boston’s Life Science Disruptors 09/20/17 Boston
Dragonfly, Tyler Jacks Sign On for Boston’s Life Science Disruptors on Sept. 28 08/09/17 Boston
Check Out Tesaro & More at “Disruptors” on Sept. 28; Super Saver Rate Ends Today 08/03/17 Boston
Join Tesaro and Others at Boston’s Life Science Disruptors Sept. 28 07/13/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Next Stop on Father’s Duchenne Quest: Wall Street? Solid Raises $50M 03/30/17 Boston
Pfizer Continues Gene Therapy Push With $150M Bamboo Buyout 08/01/16 Raleigh Durham
Page 1 of 2 next page »